|
Real-time Estimate
Cboe BZX
23:48:07 15/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 87.44 USD | +4.75% |
|
+3.57% | +31.72% |
| 10-15 | DexCom, Inc. Announces Publication Of CONNECT Study Results For Dexcom G7 In The New England Journal Of Medicine | CI |
| 10-13 | Mizuho Adjusts Price Target on DexCom to $100 From $95 | MT |
| Market Cap | 31.5B 28.12B 26.13B 23.77B 44.72B 2,983B 45.52B 314B 123B 1,557B 118B 116B 4,981B | P/E 2026 * |
33.5x | P/E 2027 * | 28.3x |
|---|---|---|---|---|---|
| Enterprise Value | 30.74B 27.44B 25.5B 23.19B 43.64B 2,911B 44.42B 306B 120B 1,519B 115B 113B 4,861B | EV / Sales 2026 * |
5.88x | EV / Sales 2027 * | 5.25x |
| Free-Float |
91.27% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DXCM | Delayed | |
CBOE
| DXCM | Real-time | |
|
Tradegate
| DC4 | Real-time | |
|
Mexican S.E.
| DXCM * | End-of-day quote | |
|
Boerse Muenchen
| DC4 | Real-time | |
|
London S.E.
| 0A4M | Delayed | |
|
Borsa Italiana
| 1DXCM | End-of-day quote | |
|
Xetra
| DC4 | Delayed | |
|
Deutsche Boerse AG
| DC4 | Delayed | |
|
Börse Stuttgart
| DC4 | Delayed | |
|
Wiener Boerse
| DXCM | End-of-day quote | |
|
Swiss Exchange
| DXCM | Delayed | |
|
Swiss Exchange
| DXCM | Delayed |
Last Transcript: DexCom, Inc.
| 1 day | +4.84% | ||
| 1 week | +3.57% | ||
| Current month | +1.31% | ||
| 1 month | +1.12% | ||
| 3 months | +20.20% | ||
| 6 months | +42.05% | ||
| Current year | +31.72% |
| 1 week | 82.94 |  | 87.88 |
| 1 month | 82.86 | | 90.38 |
| Current year | 56.72 | | 92.59 |
| 1 year | 54.11 | | 92.59 |
| 3 years | 54.11 | | 142 |
| 5 years | 54.11 | | 164.86 |
| 10 years | 10.66 | | 164.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacob Leach
CEO | Chief Executive Officer | 47 | 01/01/2026 |
Jereme Sylvain
DFI | Director of Finance/CFO | 46 | 19/03/2021 |
Stacey Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Sayer
CHM | Chairman | 68 | 30/07/2018 |
Nick Augustinos
BRD | Director/Board Member | 67 | 20/11/2009 |
Jacob Leach
BRD | Director/Board Member | 47 | 01/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/09/26 | Sell | Head of Human Resources | -2,565 | 0.0007% | ||
| 15/09/26 | Sell | Compliance Officer | -1,700 | 0.0005% | ||
| 15/09/26 | Sell | Director | -6,539 | 0.0017% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.75% | +3.57% | +33.65% | +10.73% | 31.5B | |
| +2.28% | +6.57% | -18.92% | +13.86% | 178B | |
| +1.49% | +8.99% | +0.31% | +33.29% | 121B | |
| +3.87% | +5.98% | -20.61% | +11.15% | 108B | |
| +0.41% | +3.99% | -44.97% | -10.22% | 75.7B | |
| +1.29% | +6.03% | +6.61% | +82.35% | 64.15B | |
| -1.75% | -0.72% | +17.66% | +59.66% | 53.49B | |
| +2.76% | +6.19% | +3.91% | -25.29% | 51.45B | |
| +2.99% | +6.28% | -14.67% | +26.97% | 41.68B | |
| +2.32% | +2.66% | - | - | 31.52B | |
| Average | +2.13% | +3.28% | -4.11% | +22.50% | 75.62B | |
| Weighted average by Cap. | +2.09% | +4.09% | -9.58% | +21.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.23B 4.67B 4.34B 3.95B 7.42B 495B 7.56B 52.11B 20.39B 258B 19.62B 19.21B 827B | 5.79B 5.17B 4.81B 4.37B 8.22B 549B 8.37B 57.73B 22.59B 286B 21.74B 21.28B 916B |
| Net income | 973M 869M 807M 734M 1.38B 92.16B 1.41B 9.7B 3.79B 48.09B 3.65B 3.57B 154B | 1.15B 1.02B 951M 865M 1.63B 109B 1.66B 11.42B 4.47B 56.62B 4.3B 4.21B 181B |
| Net Debt | -761M -679M -631M -574M -1.08B -72.09B -1.1B -7.58B -2.97B -37.61B -2.86B -2.8B -120B | -1.06B -947M -881M -801M -1.51B -101B -1.53B -10.58B -4.14B -52.46B -3.98B -3.9B -168B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | $87.55 | +4.89% | 2,635,903 |
| 14/10/26 | $83.47 | -1.87% | 3,481,314 |
| 13/10/26 | $85.06 | -1.00% | 4,017,079 |
| 12/10/26 | $85.92 | +2.15% | 2,992,133 |
| 09/10/26 | $84.11 | -0.36% | 3,154,204 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DXCM Stock
Select your edition
All financial news and data tailored to specific country editions
